References
- Kitamura Y. Heterogeneity of mast cells and phenotypic change between subpopulations. Annu Rev Immunol. 1989;7:59–76.
- Blank U, Essig M, Scandiuzzi L, Benhamou M, Kanamaru Y. Mast cells and inflammatory kidney disease. Immunol Rev. 2007;217:79–95.
- Armbrust T, Batusic D, Ringe B, Ramadori G. Mast cells distribution in human liver disease and experimental rat liver fibrosis. Indications for mast cell participation in development of liver fibrosis. J Hepatol. 1997;26:1042–1054.
- Roberts IS, Brenchley PE. Mast cells: The forgotten cells of renal fibrosis. J Clin Pathol. 2000;53:858–862.
- Holdsworth SR, Allen DE, Thomson NM, Glasgow EF, Atkins RC. Histochemistry of glomerular cells in animal models of crescentic glomerulonephritis. Pathology. 1980;12:339–346.
- Zheng JM, Yao GH, Cheng Z, et al. Pathogenic role of mast cells in the development of diabetic nephropathy: A study of patients at different stages of the disease. Diabetologia. 2012;55:801–811.
- Tóth T, Tóth-Jakatics R, Jimi S, Ihara M, Urata H, Takebayashi S. Mast cells in rapidly progressive glomerulonephritis. J Am Soc Nephrol. 1999;10:1498–1505.
- Timoshanko JR, Kitching AR, Semple TJ, Tipping PG, Holdsworth SR. A pathogenetic role for mast cells in experimental crescentic glomerulonephritis. J Am Soc Nephrol. 2006;17:150–159.
- Hochegger K, Siebenhaar F, Vielhauer V, et al. Role of mast cells in experimental anti-glomerular basement membrane glomerulonephritis. Eur J Immunol. 2005;35:3074–3082.
- Kanamaru Y, Scandiuzzi L, Essig M, et al. Mast cell-mediated remodeling and fibrinolytic activity protect against fatal glomerulonephritis. J Immunol. 2006;176:5607–5615.
- Cui Z, Zhao MH, Xin G, Wang HY. Characteristics and prognosis of Chinese patients with antiglomerular basement membrane disease. Nephron Clin Pract. 2005;99:c49–c55.
- Kondo S, Kagami S, Kido H, Strutz F, Müller GA, Kuroda Y. Role of mast cell tryptase in renal interstitial fibrosis. J Am Soc Nephrol. 2001;12:1668–1676.
- Ferrario F, Castiglione A, Colasanti G, Barbiano di Belgioioso G, Bertoli S, D’Amico G. The detection of monocytes in human glomerulonephritis. Kidney Int. 1985;28:513–519.
- Tang Z, Wu Y, Hu W, et al. The distribution and significance of renal infiltrating cells in patients with diffuse crescentic glomerulonephritis. Chin Med J (Engl). 2001;114:1267–1269.
- Berden AE, Ferrario F, Hagen EC, et al. Histopathologic classification of ANCA-associated glomerulonephritis. J Am Soc Nephrol. 2010;21:1628–1636.
- Daly C, Conlon PJ, Medwar W, Walshe JJ. Characteristics and outcome of anti-glomerular basement membrane disease: A single-center experience. Ren Fail. 1996;18:105–112.
- Levy JB, Turner AN, Rees AJ, Pusey CD. Long term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression. Ann Intern Med. 2001;134:1033–1042.
- Jindal KK. Management of idiopathic crescentic and diffuse proliferative glomerulonephritis: Evidence-based recommendations. Kidney Int Suppl. 1999;70:S33–S40.
- Kitching AR, Holdsworth SR, Tipping PG. Crescentic glomerulonephritis – A manifestation of a nephritogenic Th1 response? Histol Histopathol. 2000;15:993–1003.
- El Nahas AM. Glomerulosclerosis: Intrinsic and extrinsic pathways. Nephrol Dial Transplant. 1996;11:773–777.
- Holdsworth SR, Summers SA. Role of mast cells in progressive renal diseases. J Am Soc Nephrol. 2008;19:2254–2261.
- El-Koraie AF, Baddour NM, Adam AG, El Kashef EH, El Nahas AM. Role of stem cell factor and mast cells in the progression of chronic glomerulonephritides. Kidney Int. 2001;60:167–172.
- Kobori H, Nangaku M, Navar LG, Nishiyama A. The intrarenal renin–angiotensin system: From physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev. 2007;59:251–287.
- Mackins CJ, Kano S, Seyedi N, et al. Cardiac mast cell-derived renin promotes local angiotensin formation, norepinephrine release, and arrhythmias in ischemia/reperfusion. J Clin Invest. 2006;116:1063–1070.
- Jones SE, Kelly DJ, Cox AJ, Zhang Y, Gow RM, Gilbert RE. Mast cell infiltration and chemokine expression in progressive renal disease. Kidney Int. 2003;64:906–913.
- Silver RB, Reid AC, Mackins CJ, et al. Mast cells: A unique source of renin. Proc Natl Acad Sci USA. 2004;101:13607–13612.
- Chevalier RL, Forbes MS, Thornhill BA. Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy. Kidney Int. 2009;75:1145–1152.
- Atkins RC. Macrophages in renal injury. Am J Kidney Dis. 1998;31:xlv–xlvii.
- Bulfone-Paus S, Bahri R. Mast cells as regulators of T cell responses. Front Immunol. 2015;6:394.
- Villa I, Skokos D, Tkaczyk C, et al. Capacity of mouse mast cells to prime T cells and to induce specific antibody responses in vivo. Immunology. 2001;102:165–172.
- Tanda S, Mori Y, Kimura T, et al. Histamine ameliorates anti-glomerular basement membrane antibody-induced glomerulonephritis in rats. Kidney Int. 2007;72:608–613.